Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,779,938
-
Total 13F shares
-
60,151,070
-
Share change
-
-1,750,828
-
Total reported value
-
$652,599,949
-
Put/Call ratio
-
47%
-
Price per share
-
$10.85
-
Number of holders
-
112
-
Value change
-
-$19,312,912
-
Number of buys
-
46
-
Number of sells
-
57
Institutional Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q1 2023
As of 31 Mar 2023,
Theravance Biopharma, Inc. - Common Stock (TBPH) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,151,070 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, Weiss Asset Management LP, Madison Avenue Partners, LP, VANGUARD GROUP INC, BlackRock Inc., Irenic Capital Management LP, Park West Asset Management LLC, BANK OF AMERICA CORP /DE/, FMR LLC, and Newtyn Management, LLC.
This page lists
112
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.